Affordable Access

deepdyve-link
Publisher Website

New Poly(3-hydroxybutyrate) Microparticles with Paclitaxel Sustained Release for Intraperitoneal Administration.

Authors
  • Bonartsev, Anton P1
  • Zernov, Anton L2
  • Yakovlev, Sergey G2
  • Zharkova, Irina I3
  • Myshkina, Vera L2
  • Mahina, Tatiana K2
  • Bonartseva, Garina A2
  • Andronova, Natalia V4
  • Smirnova, Galina B4
  • Borisova, Juliya A4
  • Kalishjan, Mikhail S4
  • Shaitan, Konstantin V3
  • Treshalina, Helena M4
  • 1 Faculty of Biology, Moscow State University, Leninskie gory, 1-12, Moscow 119991, Russian Federation. , (Russia)
  • 2 A.N. Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow, Russian Federation. , (Russia)
  • 3 Faculty of Biology, Moscow State University, Moscow, Russian Federation. , (Russia)
  • 4 Federal State Budgetary Institution «N.N. Blokhin Russian Cancer Research Center», Moscow, Russian Federation. , (Russia)
Type
Published Article
Journal
Anti-cancer agents in medicinal chemistry
Publication Date
Jan 01, 2017
Volume
17
Issue
3
Pages
434–441
Identifiers
DOI: 10.2174/1871520615666160504095433
PMID: 27141874
Source
Medline
Keywords
License
Unknown

Abstract

The developed technique of PTX sustained delivery from PHB-microparticles has therapeutic potential as prolong anticancer drug formulation.

Report this publication

Statistics

Seen <100 times